Johnson Louise N
Laboratory of Molecular Biophysics, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Biochem Soc Trans. 2009 Aug;37(Pt 4):627-41. doi: 10.1042/BST0370627.
Phosphorylation plays essential roles in nearly every aspect of cell life. Protein kinases regulate signalling pathways and cellular processes that mediate metabolism, transcription, cell-cycle progression, differentiation, cytoskeleton arrangement and cell movement, apoptosis, intercellular communication, and neuronal and immunological functions. Protein kinases share a conserved catalytic domain, which catalyses the transfer of the gamma-phosphate of ATP to a serine, threonine or tyrosine residue in protein substrates. The kinase can exist in an active or inactive state regulated by a variety of mechanisms in different kinases that include control by phosphorylation, regulation by additional domains that may target other molecules, binding and regulation by additional subunits, and control by protein-protein association. This Novartis Medal Lecture was delivered at a meeting on protein evolution celebrating the 200th anniversary of Charles Darwin's birth. I begin with a summary of current observations from protein sequences of kinase phylogeny. I then review the structural consequences of protein phosphorylation using our work on glycogen phosphorylase to illustrate one of the more dramatic consequences of phosphorylation. Regulation of protein phosphorylation is frequently disrupted in the diseased state, and protein kinases have become high-profile targets for drug development. Finally, I consider recent advances on protein kinases as drug targets and describe some of our recent work with CDK9 (cyclin-dependent kinase 9)-cyclin T, a regulator of transcription.
磷酸化在细胞生命的几乎每个方面都起着至关重要的作用。蛋白激酶调节信号通路和细胞过程,这些过程介导新陈代谢、转录、细胞周期进程、分化、细胞骨架排列和细胞运动、细胞凋亡、细胞间通讯以及神经元和免疫功能。蛋白激酶共享一个保守的催化结构域,该结构域催化将ATP的γ-磷酸基团转移到蛋白质底物中的丝氨酸、苏氨酸或酪氨酸残基上。激酶可以以活性或非活性状态存在,其受不同激酶中多种机制的调节,这些机制包括磷酸化控制、由可能靶向其他分子的附加结构域进行调节、由附加亚基进行结合和调节以及通过蛋白质-蛋白质相互作用进行控制。本次诺华奖章讲座是在一次庆祝查尔斯·达尔文诞辰200周年的蛋白质进化会议上发表的。我首先总结一下目前从激酶系统发育的蛋白质序列中观察到的情况。然后,我将利用我们在糖原磷酸化酶方面的工作来回顾蛋白质磷酸化的结构后果,以说明磷酸化的一个更为显著的后果。在疾病状态下,蛋白质磷酸化的调节经常被破坏,蛋白激酶已成为药物开发的热门靶点。最后,我将探讨蛋白激酶作为药物靶点的最新进展,并描述我们最近在CDK9(细胞周期蛋白依赖性激酶9)-细胞周期蛋白T(一种转录调节因子)方面的一些工作。